PRAX (STOCKS)
Praxis Precision Medicines, Inc. Common Stock
$332.920000
+9.630000 (+2.98%)
Prev close: $323.290000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marcio Souza
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,124.10M
- Employees
- 82
- P/E (TTM)
- -25.80
- P/B (TTM)
- 19.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
12
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-3.36 | $-3.51 | +0.1509 | +4.30% |
|
Jun 2025 (Q2)
|
$-3.31 | $-3.40 | +0.0874 | +2.57% |
|
Mar 2025 (Q1)
|
$-3.29 | $-3.27 | -0.0250 | -0.77% |
|
Dec 2024 (Q4)
|
$-2.94 | $-2.90 | -0.0362 | -1.25% |
Financial Statements
| Revenues | $7.46M |
| Nonoperating Income/Loss | $20.07M |
| Operating Expenses | $300.57M |
| Research and Development | $245.90M |
| Other Operating Expenses | $54.68M |
| Operating Income/Loss | -$293.11M |
| Income/Loss From Continuing Operations After Tax | -$273.04M |
| Income/Loss From Continuing Operations Before Tax | -$273.04M |
| Net Income/Loss | -$273.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$273.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$273.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$12.97 |
| Diluted Earnings Per Share | -$12.97 |
| Basic Average Shares | 22,202,211 |
| Diluted Average Shares | 22,202,211 |
| Assets | $396.39M |
| Current Assets | $273.84M |
| Cash | $389.20M |
| Noncurrent Assets | $122.54M |
| Fixed Assets | $174.00K |
| Other Non-current Assets | $122.37M |
| Liabilities | $52.88M |
| Current Liabilities | $52.88M |
| Accounts Payable | $30.82M |
| Other Current Liabilities | $22.06M |
| Noncurrent Liabilities | $0.00 |
| Equity | $343.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $343.51M |
| Liabilities And Equity | $396.39M |
| Net Cash Flow From Operating Activities | -$228.87M |
| Net Cash Flow From Operating Activities, Continuing | -$228.87M |
| Net Cash Flow From Investing Activities | $6.33M |
| Net Cash Flow From Investing Activities, Continuing | $6.33M |
| Net Cash Flow From Financing Activities | $203.42M |
| Net Cash Flow From Financing Activities, Continuing | $203.42M |
| Net Cash Flow | -$19.12M |
| Net Cash Flow, Continuing | -$19.12M |
| Comprehensive Income/Loss | -$273.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$273.19M |
| Other Comprehensive Income/Loss | -$214.51M |